drugset / Trial / NCT07660536

To Study the Efficacy and Safety of Doxercalciferol on Spinal and Femoral Density in Postmenopausal Osteopenic Women in a Long Term 2 Year Study

NCT07660536

Phase 2/3 Completed 60 enrolled Creighton University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

A clinical trial to compare the effect of doxercalciferol or placebo in preventing bone loss from the spine and femur in postmenopausal women

Timeline

Start
1989-11-14
Primary completion
1992-04-22
Completion
1994-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxercalciferol Small molecule 5 ug Oral

Indications